US 11530196
Pyrimidine compound acting on EGFR and ERBB2
granted A61PA61P35/00
Quick answer
US patent 11530196 (Pyrimidine compound acting on EGFR and ERBB2) held by CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00